133 related articles for article (PubMed ID: 25512163)
41. Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients.
Kovacs G; Sipeki N; Suga B; Tornai T; Fechner K; Norman GL; Shums Z; Antal-Szalmas P; Papp M
PLoS One; 2018; 13(3):e0194166. PubMed ID: 29590158
[TBL] [Abstract][Full Text] [Related]
42. Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn's disease.
Kohoutova D; Drahosova M; Moravkova P; Rejchrt S; Bures J
BMC Gastroenterol; 2014 Dec; 14():190. PubMed ID: 25551469
[TBL] [Abstract][Full Text] [Related]
43. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
44. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W
Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572
[TBL] [Abstract][Full Text] [Related]
45. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease.
Rump JA; Schölmerich J; Gross V; Roth M; Helfesrieder R; Rautmann A; Lüdemann J; Gross WL; Peter HH
Immunobiology; 1990 Nov; 181(4-5):406-13. PubMed ID: 2099908
[TBL] [Abstract][Full Text] [Related]
46. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.
Colombel JF; Reumaux D; Duthilleul P; Noël LH; Gower-Rousseau C; Paris JC; Cortot A
Gastroenterol Clin Biol; 1992; 16(8-9):656-60. PubMed ID: 1426820
[TBL] [Abstract][Full Text] [Related]
47. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L
Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
[TBL] [Abstract][Full Text] [Related]
48. [Predictive value of serological tests in the diagnosis of celiac disease].
Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
[TBL] [Abstract][Full Text] [Related]
49. [Clinical importance of organ-specific antibodies in ulcerative colitis and Crohn disease].
Goischke EM; Zilly W
Z Gastroenterol; 1992 May; 30(5):319-24. PubMed ID: 1378673
[TBL] [Abstract][Full Text] [Related]
50. [Assessment of antibodies anti-saccharomyces cerevisiae (ASCA) and autoantibodies in patients with inflammatory bowel disease].
Beltrão M; Bodas A; Azevedo F; Nunes A; Santos C; Delgado L
Acta Med Port; 2010; 23(5):829-36. PubMed ID: 21144323
[TBL] [Abstract][Full Text] [Related]
51. [Comparison of five techniques to detect anti-Saccharomyces cerevisiae antibodies (ASCA) in serum for diagnosing Crohn's disease].
Le Goff C; Chapelle JP; Lutteri L
Ann Biol Clin (Paris); 2007; 65(6):601-8. PubMed ID: 18039604
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
Bansi DS; Chapman RW; Fleming KA
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
[TBL] [Abstract][Full Text] [Related]
53. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
Gao X; Hu PJ; He Y; Liao SY; Peng S; Chen MH
Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):428-30. PubMed ID: 16008854
[TBL] [Abstract][Full Text] [Related]
54. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
Kull K; Salupere R; Uibo R; Ots M; Salupere V
Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
[TBL] [Abstract][Full Text] [Related]
55. Crohn's disease-specific anti-CUZD1 pancreatic antibodies are absent in ruminants with paratuberculosis.
Liaskos C; Spyrou V; Athanasiou LV; Orfanidou T; Mavropoulos A; Rigopoulou EI; Amiridis GS; Shoenfeld Y; Billinis C; Bogdanos DP
Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):384-90. PubMed ID: 25575461
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic and clinical significance of antigen-specific pancreatic antibodies in inflammatory bowel diseases: A meta-analysis.
Gkiouras K; Grammatikopoulou MG; Theodoridis X; Pagkalidou E; Chatzikyriakou E; Apostolidou AG; Rigopoulou EI; Sakkas LI; Bogdanos DP
World J Gastroenterol; 2020 Jan; 26(2):246-265. PubMed ID: 31988587
[TBL] [Abstract][Full Text] [Related]
57. Distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn's disease.
Reumaux D; Mézière C; Colombel JF; Duthilleul P; Mueller S
Clin Immunol Immunopathol; 1995 Dec; 77(3):349-57. PubMed ID: 7586746
[TBL] [Abstract][Full Text] [Related]
58. Loss of tolerance to one or two major targets in Crohn's disease or just cross-reactivity?
Roggenbuck D; Bogdanos D; Conrad K
J Crohns Colitis; 2013 Aug; 7(7):e273-4. PubMed ID: 23337370
[No Abstract] [Full Text] [Related]
59. IgA autoreactivity: a feature common to inflammatory bowel and connective tissue diseases.
Kazemi-Shirazi L; Gasche CH; Natter S; Gangl A; Smolen J; Spitzauer S; Valent P; Kraft D; Valenta R
Clin Exp Immunol; 2002 Apr; 128(1):102-9. PubMed ID: 11982597
[TBL] [Abstract][Full Text] [Related]
60. Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease.
Deutschmann C; Sowa M; Murugaiyan J; Roesler U; Röber N; Conrad K; Laass MW; Bogdanos D; Sipeki N; Papp M; Rödiger S; Roggenbuck D; Schierack P
J Crohns Colitis; 2019 Jul; 13(7):894-904. PubMed ID: 30753386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
